BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents April 2, 2017 Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation November 29, 2017 GlaxoSmithKline Gets Expanded FDA Win for Fluarix January 11, 2018
United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents April 2, 2017
Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation November 29, 2017
